INCR News and Press, Intercure Ltd. From 11/14/22

Summary Ayr Wellness has made big investments in growth over multiple years. As the investment cycle wraps up, management looks toward the payoff. Ayr's prospects are evaluated in light of the capital position and latest financial results. Introduction When I f...

InterCure ( NASDAQ: INCR ) said Friday it expects to report record Q3 revenue of C$39M, up 63% Y/Y,  driven by strong demand for its branded products. The company said its annualized run rate was over C$155M, with revenue growth expected to continue in Q4. As...

Estimated revenue reaches CAD$39 million 1 (a record of over NIS 100 million) : Eleventh consecutive quarter of profitable growth with revenue growth expected to continue in Q4 2022 NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 11, 2022 (GLO...

Summary Legal cannabis around the world is just beginning but will surpass that of North America. Europe is one of the largest growth markets for companies in global cannabis. InterCure is well positioned to take advantage of European cannabis growth. For...

Summary InterCure is the leading cannabis operator in Israel. Israel is currently a medical market, with recreational legalization expected to occur over the coming years. An astonishing 27% of adults in Israel use cannabis - far higher than in any other country. InterCure...

HERZLIYA, Israel, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Intercure Ltd. (the “Company”) announces today the results of the Annual and Special General Meeting of shareholders of the Company, held on Thursday, September 15, 2022, in Bnei Brak, Israel (the “Meeting”). A...

Summary The global cannabis market will eventually be far bigger than North America. InterCure is a leading company in global pharmaceutical cannabis. Investors can still get in early while most attention is focused elsewhere. InterCure's Chairman is a national hero and fo...

InterCure Ltd (INCR) Q2 2022 Earnings Conference Call August 16, 2022, 08:30 ET Company Participants Adam Haliva - Communications Officer Alexander Rabinovitch - CEO & Director Amos Cohen - CFO Conference Call Participants Victor Ma - Cowen and Co...

InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) posted positive results despite barely missing revenue expectations, as the company looks to further its international reach and shore up it’s new-found partnerships . The Israeli-based cannabis company — also ...

InterCure press release ( NASDAQ: INCR ): Q2 net income of $6M, representing a 160% Y/Y growth Revenue of $37M. Adjusted EBITDA increased 90% year-over-year to $9 million, representing 23% of revenues and 4% sequential growth. For further details see: InterCu...